Alkermes (ALKS) Misses Q2 EPS by 13c, Post FY11 Guidance
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $24.32 +1.04%
Revenue Growth %: +26.3%
Financial Fact:
Royalty revenues: 9.44M
Today's EPS Names:
SFST, VLTO, CLIR, More
Revenue Growth %: +26.3%
Financial Fact:
Royalty revenues: 9.44M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q2 EPS of ($0.22), $0.13 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $72 million versus the consensus estimate of $67.71 million.
Alkermes sees FY2012 EPS of $-0.89-$-0.78, versus prior guidance of $-0.47-$0.38 and the consensus of $-0.21. Alkermes sees FY2012 revenue of $350-$380 million, versus prior guidance of $205-$229 million and the consensus of $377.32 million.
Alkermes sees FY2012 EPS of $-0.89-$-0.78, versus prior guidance of $-0.47-$0.38 and the consensus of $-0.21. Alkermes sees FY2012 revenue of $350-$380 million, versus prior guidance of $205-$229 million and the consensus of $377.32 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enphase Energy (ENPH) Misses Q1 EPS by 7c, misses on guidance
- Kiniksa Pharmaceuticals, Ltd. (KNSA) Misses Q1 EPS by 11c; raises guidance
- East-West Bancorp (EWBC) Tops Q1 EPS by 11c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
